New horizons in the pathogenesis, pathophysiology and treatment of familial hypercholesterolaemia
author
Viigimaa, Margus
Heinsar, Silver
Lovic, Dragan
Katsimardou, Alexandra
Piperidou, Alexia
Duishvili, Davit
statement of authorship
Margus Viigimaa, Silver Heinsar, Dragan Lovic, Alexandra Katsimardou, Alexia Piperidou, Davit Duishvili
source
Current pharmaceutical design
publisher
Bentham Science Publishers
journal volume number month
vol. 24, 31
year of publication
2018
pages
p. 3599-3604
url
https://doi.org/10.2174/1381612824666181009105305
subject term
hüperkolesteroleemia
patogenees
patoloogilis-füsioloogilised aspektid
LDL retseptorid
apolipoproteiin-B
inhibiitorid
keyword
familial hypercholesterolaemia
pathogenesis
pathophysiology
LDL receptor
apolipoprotein B
PCSK9
autosomal recessive hypercholesterolaemia
ISSN
1381-6128
notes
Bibliogr.: 74 ref
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
https://www.scopus.com/sourceid/20682
https://www.scopus.com/record/display.uri?eid=2-s2.0-85060024681&origin=inward&txGid=23d487431ca81928057cd9221a82c69d
WOS
https://jcr.clarivate.com/jcr-jp/journal-profile?journal=CURR%20PHARM%20DESIGN&year=2022
https://www.webofscience.com/wos/woscc/full-record/WOS:000454705800002
category (general)
Pharmacology, toxicology and pharmaceutics
Farmakoloogia, toksikoloogia ja farmaatsia
category (sub)
Pharmacology, toxicology and pharmaceutics. Pharmacology
Farmakoloogia, toksikoloogia ja farmaatsia. Farmakoloogia
Pharmacology, toxicology and pharmaceutics. Drug discovery
Farmakoloogia, toksikoloogia ja farmaatsia. Narkootikumide avastamine
quartile
Q3
TalTech department
tervisetehnoloogiate instituut
language
inglise